Lung cancer screening found cost-effective for Medicare

Lung cancer screening found cost-effective for medicare

(HealthDay)—Low-dose computed tomography (LDCT) is a low-cost and cost-effective strategy for screening Medicare beneficiaries for lung cancer, according to a study published in the August issue of American Health & Drug Benefits.

Bruce S. Pyenson, from Milliman Inc. in New York City, and colleagues estimated the cost and cost-effectiveness (cost per life-year saved) of LDCT screening in the Medicare population at high risk for lung cancer. Medicare & Medicaid Services (CMS) beneficiary files (2012) were used to establish Medicare costs, enrollment, and demographics. CMS and U.S. Census Bureau projections were used for forecasts to 2014.

The researchers found that approximately 4.9 million high-risk Medicare beneficiaries would meet criteria for lung cancer screening in 2014. Without screening, Medicare patients newly diagnosed with lung cancer have an average life expectancy of approximately three years. The average annual cost of LDCT is estimated to be $241 per Medicare person screened. For Medicare beneficiaries aged 55 to 80 years with a history of ≥30 pack-years of smoking and who had smoked within 15 years, assuming a 50 percent screening rate, LDCT screening for lung cancer is low cost, at approximately $1 per member per month. This screening demonstrates highly cost-effectiveness, at <$19,000 per life-year saved.

"If all eligible Medicare beneficiaries had been screened and treated consistently from age 55 years, approximately 358,134 additional individuals with current or past lung cancer would be alive in 2014," the authors write. "LDCT is a low-cost and cost-effective strategy that fits well within the standard Medicare benefit, including its claims payment and quality monitoring."

Several authors disclosed financial ties to the medical device industry.


Explore further

Groups call for medicare coverage of lung cancer screening

More information: Full Text

Copyright © 2014 HealthDay. All rights reserved.

Citation: Lung cancer screening found cost-effective for Medicare (2014, October 3) retrieved 15 October 2019 from https://medicalxpress.com/news/2014-10-lung-cancer-screening-cost-effective-medicare.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
 shares

Feedback to editors

User comments

Oct 04, 2014
Read my latest article, "Why Medicare Should Cover Hearing Aids." http://lnkd.in/d8tpTnV Please sign our petition to have hearing aids covered under Medicare. http://petitions....=6379786

Janice Schacter Lintz
Chair, Hearing Access Program

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more